男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Shanghai releases measures to boost biomedical industry

By Zhou Wenting in Shanghai | chinadaily.com.cn | Updated: 2018-11-07 20:21
Share
Share - WeChat

"We encourage venture capital funds to invest in emerging pharmaceutical and medical device companies, and welcome more social capital to participate in product development, result transformation and innovative system building in the city's biomedical industry," the document said.

The pharmaceutical and medical device companies also are encouraged to increase their own R&D investment, especially in new technologies, such as immune cell therapy, monoclonal antibody drugs and gene therapy, according to the document.

Another measure in the document is the establishment of a fast track of review and approval for drugs and medical devices that have obvious clinical advantages in the diagnosis or treatment of AIDS, malignant tumors, major infectious diseases, rare diseases, and diseases mainly occurring in the elderly and children.

The fast track also will be open to innovative treatment approaches, innovative medical devices that are developed for the first time in the country, those in national- or city-level research projects, and those that have clinical trails conducted at national-level centers for clinical medicine research.

A list of rare diseases in Shanghai will be drafted soon, according to the document, following the country's release of the first batch of the rare disease list, which included 121 such diseases, in May.

Registration of rare diseases in patients will be carried out more thoroughly and the government will support and encourage the development and production of therapies and medical devices for the treatment of rare diseases, the document said.

"Clinical trials can be reduced for medical devices that treat rare diseases, and for those that have been approved to be marketed in a foreign market, they will be able to be approved to be marketed in Shanghai with collateral conditions," according to the document.

|<< Previous 1 2   
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 桃源县| 大田县| 根河市| 彩票| 闻喜县| 荔浦县| 龙里县| 明星| 杭州市| 绵竹市| 凯里市| 长白| 泰顺县| 乐昌市| 大悟县| 宜都市| 东安县| 全南县| 上杭县| 新建县| 无锡市| 颍上县| 赣榆县| 五寨县| 绥阳县| 通海县| 乳山市| 景洪市| 恩施市| 岱山县| 孟连| 普定县| 宁安市| 铁力市| 南江县| 青川县| 阳原县| 寿光市| 瑞安市| 阿拉善盟| 疏勒县|